ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 917,09
-0,85%
Dow Jones
37 903,29
0,23%
DAX
17 907,70
-0,08%
Brent Oil
84,205
0,80%
Bitcoin
57 789,86
-0,77%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. aTyr Pharma Inc (LIFE)

  7. aTyr Pharma Inc (LIFE) Actualités

LIFE aTyr Pharma Inc

1,59
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:00:01
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
aTyr Pharma Inc LIFE NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 1,59 10:00:01
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,59
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/4/202414:00GLOBEaTyr Pharma to Participate in April Investor Conferences
14/3/202421:00GLOBEaTyr Pharma Announces Fourth Quarter and Full Year 2023..
28/2/202414:00GLOBEaTyr Pharma to Webcast Conference Call Reporting Fourth..
21/2/202414:00GLOBEaTyr Pharma Announces Expanded Access Program (EAP) for..
07/2/202402:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202414:00GLOBEaTyr Pharma to Present Posters Highlighting Importance of..
18/1/202414:00GLOBEaTyr Pharma Announces Howard University President Emeritus..
10/1/202401:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202401:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202418:21EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/12/202300:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
13/11/202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202314:00GLOBEaTyr Pharma Presents Poster Demonstrating Preclinical..
09/11/202323:01EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202322:42EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/11/202322:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:06EDGAR2Form 8-K - Current report
09/11/202322:00GLOBEaTyr Pharma Announces Third Quarter 2023 Results and..
01/11/202313:00GLOBEaTyr Pharma to Present at November Investor Conferences
31/10/202313:00GLOBEaTyr Pharma Announces Dosing of First Patient in Phase 2..
26/9/202315:01EDGAR2Form 8-K - Current report
11/9/202314:04EDGAR2Form 8-K - Current report
11/9/202314:00GLOBEaTyr Pharma Presents Efzofitimod Data Demonstrating..
24/8/202314:00GLOBEaTyr Pharma to Present at the H.C. Wainwright 25th Annual..
10/8/202322:07EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/8/202322:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:10EDGAR2Form 8-K - Current report
09/8/202322:00GLOBEaTyr Pharma Announces Second Quarter 2023 Results and..
01/8/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/6/202314:00GLOBEEuropean Commission Grants Orphan Drug Designation for aTyr..
20/6/202314:00GLOBEaTyr Pharma to Present on Lead Therapeutic Candidate..
09/6/202322:00GLOBEaTyr Pharma Announces Inducement Grants Under Nasdaq Listing..
06/6/202314:00GLOBEaTyr Pharma to Highlight Advancements in tRNA Synthetase..
25/5/202314:00GLOBEaTyr Pharma to Present at the 2023 Jefferies Healthcare..
22/5/202314:00GLOBEaTyr Pharma Presents New Data on Efzofitimod Mechanism of..
11/5/202322:00GLOBEaTyr Pharma to Present at the 2023 RBC Capital Markets..
09/5/202322:00GLOBEaTyr Pharma Announces First Quarter 2023 Results and..

Dernières Valeurs Consultées

NASDAQ
LIFE
aTyr Pharma
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés